$BYSI
BeyondSpring Inc. Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
$0.600
▲+0.03%+$0.000Market closed
BeyondSpring Inc. Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is BYSI up today? It is at $0.600 (+0.03%), and our scanner flagged it 7 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BYSI spikes, and full due diligence on BYSI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BYSI 7 times in the last 30 days. Create a free account to track $BYSI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BYSI from our scanner (live price and day move above). Fresh from the SEC: BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystBeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate UpdateReported Net loss was $2.1 million for the quarter ended September 30, 2026, compared to $1.6 million for the quarter ended September 30, 2025.Reported Cash, cash equivalents, and short-term investments were $0.6 million as of September 30, 2026, compared to $4.0 million as of December 31, 2025.Reported Net loss was $5.7 million for the nine months ended September 30, 2026, compared to $5.8 million for the nine months ended September 30, 2025., from the latest SEC filing. Read it →Across every filing on file, supply equal to 26.9% of the tradeable float is in play - 26.9% more can still be issued.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
9,200,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $11.9M in size · Priced at $0.7772/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Huang Lan Officer | Sold (automatic/other) | -261K 0.6% of company | sold 35% | 477K | n/a | Mar 20, 26 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -46K 0.1% of company | sold 1.1% | 4.03M | $80K at $1.76 | Oct 17, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -86K 0.2% of company | sold 5.2% | 1.56M | $148K at $1.72 | Oct 16, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -18K 0.04% of company | sold 0.4% | 4.16M | $30K at $1.65 | Oct 15, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -28K 0.07% of company | sold 1.7% | 1.67M | $47K at $1.65 | Oct 14, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -107K 0.3% of company | sold 6.0% | 1.70M | $183K at $1.70 | Oct 13, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -2K | sold <0.1% | 4.31M | $4K at $1.77 | Oct 10, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -4K | sold 0.2% | 1.81M | $7K at $1.81 | Oct 9, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -8K 0.02% of company | sold 0.4% | 1.81M | $13K at $1.77 | Oct 8, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -2K | sold <0.1% | 4.33M | $4K at $1.79 | Oct 7, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -18K 0.04% of company | sold 1.0% | 1.82M | $31K at $1.78 | Oct 6, 25 |
Decheng Capital China Life Sciences Usd Fund Iii, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -600 | sold <0.1% | 1.84M | $1K at $1.76 | Oct 3, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BYSI from our scanner (live price and day move above). Fresh from the SEC: BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update. A material company disclosure like this is often the real catalyst behind a move of this size.
BYSI last traded at $0.600, up 0.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The BYSI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BYSI 7 times in the last 30 days.
BYSI (BeyondSpring Inc. Ordinary Shares) trades on XNAS, with a market cap of about $25M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BYSI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BYSI discussion
Sign in to ask a question or join the discussion.